Literature DB >> 22962308

Dabigatran-induced acute hepatitis.

Bram Rochwerg, Ted Xenodemetropoulos, Mark Crowther, Alex Spyropoulos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22962308     DOI: 10.1177/1076029611435840

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


× No keyword cloud information.
  6 in total

Review 1.  Hepatotoxicity of New Oral Anticoagulants (NOACs).

Authors:  Evangelia Liakoni; Alexandra E Rätz Bravo; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2015-08       Impact factor: 5.606

2.  Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation.

Authors:  Alvaro Alonso; Richard F MacLehose; Lin Y Chen; Lindsay Gs Bengtson; Alanna M Chamberlain; Faye L Norby; Pamela L Lutsey
Journal:  Heart       Date:  2017-01-05       Impact factor: 5.994

3.  Dabigatran overdose: a case report of acute hepatitis. Extracorporeal treatment.

Authors:  Mariagrazia Porru; Antonella Mameli; Maria E Cianchetti; Mario Musu; Paola Schirru; Maria F Ruberto; Doris Barcellona; Francesco Marongiu
Journal:  Int J Hematol       Date:  2016-12-01       Impact factor: 2.490

4.  Rhabdomyolysis happened after the start of dabigatran etexilate treatment: A case report.

Authors:  Tingting Zheng; Lulu Liu; Jiayi Liu; Zhengxiang Zhang
Journal:  J Musculoskelet Neuronal Interact       Date:  2022-06-01       Impact factor: 1.864

Review 5.  Dabigatran must be used carefully: literature review and recommendations for management of adverse events.

Authors:  Shan Lin; Yan Wang; Lei Zhang; Wei Guan
Journal:  Drug Des Devel Ther       Date:  2019-05-06       Impact factor: 4.162

6.  Non-bleeding Adverse Events with the Use of Direct Oral Anticoagulants: A Sequence Symmetry Analysis.

Authors:  Géric Maura; Cécile Billionnet; Joël Coste; Alain Weill; Anke Neumann; Antoine Pariente
Journal:  Drug Saf       Date:  2018-09       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.